YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Antibody Induced by the JY-Pol Pneumococcal Conjugate Protects Mice Against systemic Infection Due to Streptococcus pneumoniae

JY-Pol 접합백신으로 유도된 항페렴구균 항체의 보호효과

  • 이주희 (동덕여자대학교 약학대학) ;
  • 한용문 (동덕여자대학교 약학대학)
  • Published : 2004.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

We previously reported that Streptococcus pneumoniae capsule attached to the surface protein (JY-Pol) was protective to systemic pneumococcal infection. The JY -Pol antigen induced IgM, IgG, and IgA in mice and provoked cell-mediated immunity. In this current study, we investigated the effect of anti JY-Pol antiserun and monoclonal antibody C2 (Mab C2) specific for the JY-Pol antigen against the pneumococcal disease. Mice that were given the antiserum survived longer than mice that received antiserum pre-absorbed with S.pneumoniae cells or DPBS as a negative control. Heat-treated anti JY-Pol antiserum resulted in survival rates similar to intact fresh JY-Pol antiserum. Mab C2 isolated from JY-Pol-immunized mice also enhanced resistance of naive mice against the pneumococcal diseaser. This protection by Mab C2 appeared to be mediated by opsonization as determined in a RAW 264.7 monocyte/macrophage cell line. Epitope analysis showed that Mab C2 epitope consisted of glucuronic acid and glucose that blocked the interaction of JY-Pol to the C2. Taken together, these data indicate that the antiserum induced by the JY-Pol, a naturally pneumococcal conjugate formula, mediated the protection by passive transfer, which was confirmed by protective effect of Mab C2.

Keywords

References

  1. Gregory, B., Lesinski, S., Smithson, L., Srivastava, N., Chen, D., Widera, G. and Westerink, J. : A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specifec anti-carbohydrate antibodies in Balb/c mice. Vaccine 19, 1717 (2001) https://doi.org/10.1016/S0264-410X(00)00397-2
  2. Ogunniyi, A. D., Giammarinaro, P. and Paton, J. C. : The genes encoding virulence-associated proteins and the capsule of Streptococcus pneumoniae are upregulated and differentially expressed in vivo. Microbiology 148, 2045 (2002) https://doi.org/10.1099/00221287-148-7-2045
  3. Lesinski, G. B. and Westerink, M. A. : Vaccines against polysaccharide antigens. Curr. Drug. Targets. Infect. Disord. 1, 325 (2001) https://doi.org/10.2174/1568005014605964
  4. Bosarge, J. R., Watt, J. M., McDaniel, D. O., Swiatlo, E. and McDaniel, L. S. : Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae. Infect. Immun. 69, 5456 (2001) https://doi.org/10.1128/IAI.69.9.5456-5463.2001
  5. Dagan, R. : Pneumococcal conjugate vaccines : The potential to alter antibiotic use and nasopharyngeal carriage. Curr. Ther. Res. Clin Exp. 63, A22 (2002)
  6. Pelton, S. I., Dagan, R., Gaines, B. M., Klugman, K. P., Laufer, D.,O'Brien, K. and Schmitt, H. J. : Pneumococcal conjugate vaccines : proceedings from an Interactive Symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Vaccine 21, 562 (2003) https://doi.org/10.1016/S0264-410X(02)00259-1
  7. Kim, J. O. and Weiser, J. N. : Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptoeoccus pneumoniae. J. Infect. Dis. 177, 368 (1988) https://doi.org/10.1086/514205
  8. MacLeod, C. M. and Krauss, M. R. : Relation of virulence of pneumococcal strains for mice to the quantity of capsular polysaccharide formed in vitro. J. Exp. Med. 92, 1 (1950) https://doi.org/10.1084/jem.92.1.1
  9. Magee, A. D. and Yother, J. : Requirement for capsule in colonization by Streptococcus pneumoniae. Infect. Immun. 69, 3755 (2001) https://doi.org/10.1128/IAI.69.6.3755-3761.2001
  10. Tuomanen, E. I. and Masure, R. H. : Molecular and cellular biology of pneumococcal infection. In : Streptococcus pneumoniae molecular biology and mechanism of disease. Mary Ann Liebert, New York, 295 (2000)
  11. Mitchell, T. J. : Virulence factors and the pathogenesis of disease caused by Streptococcus pneumoniiae. Res. Microbiol. 151, 419 (2000)
  12. Jedrzejas, M. J. : Pneumococcal virulence factors : Structure and function. Microbio. Mol. Biol. Rev. 65, 187 (2001)
  13. Han, Y. and LJH. : A pneumococcal conjugate vaccine formula induces protection in mice against disseminated disease due to Streptococcus pneumoniae. Yak Hak Hoe Ji. (in press) (2004)
  14. Heidelberger, M., Kendall, F. E. and Scherp, H. W. : The specific ploysaccharide of Type I, II, and III pneumococcus : A revision of method and data. J. Exp. Med. 64, 559 (1936)
  15. How, M. J., Brimacombe, J. S. and Stacey, M. : The pnemococcal polysaccharides. Adv. Carbohyd. Chem. 19, 303 (1964)
  16. Han, Y. and Cutler, J. E. : Antibody response that protects against disseminated candidiasis. Infect. Immun. 63, 2714 (1995)
  17. Han, Y. and Cutler, J. E. : Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. J. Infect. Dis. 175, 1169 (1997) https://doi.org/10.1086/516455
  18. Han, Y., Jin , B. S., Ko, S. K. and Lee, J.-H. Immunoactivity of ginsenosides re and rg1 that enhances resistance of mice against experimental disseminated candidiasis. Nat. Prod. Sci. 10, 134 (2004)
  19. Lesinski, G. B., Smithson, S. L., Srivastava, N., Chen, D., Widera, G. and Westerink, M. A. J.: A DNA vaccine encoding a peptide mimic of Streptoecoccus peumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice. Vaccine 19, 1717 (2001) https://doi.org/10.1016/S0264-410X(00)00397-2
  20. Robbins, J. B., Austrian, R., Lee, C.-J., Rastogi, S. C., Schiffman, G., Henrichsen, J., et al. : Considerations for formulating the second generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J. Infet. Dis. 148, 1136 (1983)
  21. Malley, R., Morse, S. C., Leite, L. C., Areas, A. P., Ho, P. L., Kubrusly, F. S., Almeida, I. C. and Anderson, P. : Multiserotype protection of mice against pneumococcal colonization of the nasopharynx and middle ear by killed nonencapsulated cells given intranasally with a nontoxic adjuvant. Infect. Immun. 2004 72, 4290 (2004)
  22. Areas, A. P., Oliveira, M. L., Miyaji, E. N., Leite , L. C., Aires, K. A., Dias, W. O. and Ho, P. L. : Expression and characterization of cholera toxin B-pneumococcal surface adhesin A fusion protein in Escherichia coli: ability of CTBP-PsaA to induce humoral immune response in mice. Biochem. Biophys. Res. Commun. 13, 192 (2004)
  23. Richter, M. Y., Jakobsen, H., Birgisdottir, A., Haeuw, J. F., Power, U. F., Del Giudice, G., Bartoloni, A. and Jonsdottir, I.: Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria. Infect. Immun. 72, 187 (2004) https://doi.org/10.1128/IAI.72.1.187-195.2004
  24. Smith, G. P. and Scott, J. K. : Peptide-display phage libraries. Methods Enzymol. 217, 228 (1992) https://doi.org/10.1016/0076-6879(93)17065-D
  25. Mor, G. : Plasmid DNA : A new era in vaccinology. Biochem. Pharmacol. 55, 1151 (1998)